Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease or NAFLD) is a type of liver disease that is not caused by alcohol. It typically doe...
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning metabolic dysfunction-associated steatotic liver disease
Updated Feb 4, 2026
Recent research identifies TRIB1AL as a potential target for steatotic liver disease through integrative genetic and liver transcriptomic analyses. This discovery could pave the way for new therapeutic strategies in managing this condition.
A new study integrates body composition analysis with machine learning to non-invasively identify metabolic dysfunction-associated fatty liver disease (MAFLD). This large-scale health examination highlights innovative approaches to diagnosing a condition affecting millions.